Getting it right the first time - Constar's Mike Mooney and Matt Dauzvardis to speak at Pack Expo
26 Octobre 2006 - 2:54PM
Business Wire
Constar�s (NASDAQ:CNST) Senior Manager of Design Engineering, Mike
Mooney, and Director of Plastic Technology, Matt Dauzvardis, will
be speaking at Pack Expo where they will outline Constar�s
CONSTruct� Advanced Predictive Engineering program, a philosophy
that the company applies to developmental projects. Mooney and
Dauzvardis will be speaking at Pack Expo as leaders from the
packaging industry converge on Chicago�s McCornmick Place. When
applied to PET bottle design CONSTruct� Advanced Predictive
Engineering helps to determine optimal weight and performance with
less need for costly redesign and test iterations. Constar has
customized conventional Finite Element Analysis (FEA) to develop
its proprietary CONSTruct� software to incorporate performance and
material properties for faster and more accurate predictions.
Constar customers benefit from better bottle performance and
lighter weight; a shorter timeframe and container aesthetics to
enhance their product�s shelf appeal. Mooney explained,
�Traditionally there have been two main customer benefits of
Predictive Engineering � lighter weight and quicker timelines.
Constar takes it to the next level by using software that was
customized in-house, CONSTruct�. This helps us to increase
accuracies and gives us the tools�to�explore more inventive and
aesthetically pleasing designs.� He added, �When we start a project
with CONSTruct�, it tends to stay on track. And getting the design
right from the beginning is what enables us to efficiently meet
project deadlines.� Philadelphia-based Constar International Inc.
is a leading global producer of PET (polyethylene terephthalate)
plastic containers for food, soft drinks and water. The company
provides full service packaging solutions, from product design and
engineering to ongoing customer support. Its customers include many
of the world�s largest consumer product companies. Constar's
(NASDAQ:CNST) Senior Manager of Design Engineering, Mike Mooney,
and Director of Plastic Technology, Matt Dauzvardis, will be
speaking at Pack Expo where they will outline Constar's
CONSTruct(TM) Advanced Predictive Engineering program, a philosophy
that the company applies to developmental projects. Mooney and
Dauzvardis will be speaking at Pack Expo as leaders from the
packaging industry converge on Chicago's McCornmick Place. When
applied to PET bottle design CONSTruct(TM) Advanced Predictive
Engineering helps to determine optimal weight and performance with
less need for costly redesign and test iterations. Constar has
customized conventional Finite Element Analysis (FEA) to develop
its proprietary CONSTruct(TM) software to incorporate performance
and material properties for faster and more accurate predictions.
Constar customers benefit from better bottle performance and
lighter weight; a shorter timeframe and container aesthetics to
enhance their product's shelf appeal. Mooney explained,
"Traditionally there have been two main customer benefits of
Predictive Engineering - lighter weight and quicker timelines.
Constar takes it to the next level by using software that was
customized in-house, CONSTruct(TM). This helps us to increase
accuracies and gives us the tools to explore more inventive and
aesthetically pleasing designs." He added, "When we start a project
with CONSTruct(TM), it tends to stay on track. And getting the
design right from the beginning is what enables us to efficiently
meet project deadlines." Philadelphia-based Constar International
Inc. is a leading global producer of PET (polyethylene
terephthalate) plastic containers for food, soft drinks and water.
The company provides full service packaging solutions, from product
design and engineering to ongoing customer support. Its customers
include many of the world's largest consumer product companies.
Constellation Pharmaceut... (NASDAQ:CNST)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Constellation Pharmaceut... (NASDAQ:CNST)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024
Real-Time news about Constellation Pharmaceuticals Inc (NASDAQ): 0 recent articles
Plus d'articles sur Constar International Inc.